Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Mar 15;91(6):2300-4.
doi: 10.1073/pnas.91.6.2300.

Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand

Affiliations

Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand

B D Evavold et al. Proc Natl Acad Sci U S A. .

Abstract

T-cell activation by an immunogenic peptide can be antagonized by nonstimulatory analogs of that peptide. We investigated this T-cell receptor antagonism by using staphylococcal enterotoxin superantigen to stimulate hemoglobin-specific helper T (Th) cells because its activation pathway may differ from that of conventional antigen. Interestingly, superantigen activation of these Th cells was antagonized by hemoglobin peptide analogs even though agonist (superantigen) and antagonist (analog peptide) bind at different sites on the major histocompatibility complex-encoded molecule and the T-cell receptor. The antagonism appeared to be a fundamental block in T-cell activation, as phosphoinositol generation, cytokine production, and proliferation were reduced in Th1 clones, and, similarly, proliferative and cytokine responses were inhibited in Th2 cells. Even T-cell hybridoma activation (cytokine production and apoptosis) was inhibited by peptide antagonists. Furthermore, analog peptides that functioned as partial agonists for these Th cells also antagonized superantigen-induced proliferation and thus were a subset of the peptide antagonists. In summary, our results demonstrate that analogs of immunogenic peptide are potent antagonists for Th cell responses induced by superantigen as well as immunogenic peptide.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Annu Rev Immunol. 1985;3:237-61 - PubMed
    1. Immunol Today. 1993 Dec;14(12):602-9 - PubMed
    1. J Exp Med. 1987 Jan 1;165(1):173-94 - PubMed
    1. J Immunol. 1988 Feb 15;140(4):1250-5 - PubMed
    1. J Exp Med. 1988 May 1;167(5):1697-707 - PubMed

Publication types

LinkOut - more resources